Future prospects for CD8 + regulatory T cells in immune tolerance - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Immunological Reviews Année : 2019

Future prospects for CD8 + regulatory T cells in immune tolerance

Résumé

CD8+ Tregs have been long described and significant progresses have been made about their phenotype, their functional mechanisms, and their suppressive ability compared to conventional CD4+ Tregs. They are now at the dawn of their clinical use. In this review, we will summarize their phenotypic characteristics, their mechanisms of action, the similarities, differences and synergies between CD8+ and CD4+ Tregs, and we will discuss the biology, development and induction of CD8+ Tregs, their manufacturing for clinical use, considering open questions/uncertainties and future technically accessible improvements notably through genetic modifications.

Mots clés

Fichier principal
Vignette du fichier
Immunological Reviews - 2019 - Flippe - Future prospects for CD8 regulatory T cells in immune tolerance.pdf (843.08 Ko) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

inserm-02341615 , version 1 (22-05-2024)

Licence

Identifiants

Citer

Léa Flippe, Séverine Bézie, Ignacio Anegon, Carole Guillonneau. Future prospects for CD8 + regulatory T cells in immune tolerance. Immunological Reviews, 2019, ⟨10.1111/imr.12812⟩. ⟨inserm-02341615⟩
33 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More